Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast with Methotrexate in Active Rheumatoid Arthritis
NCT00882024Phase 2Completed
- Sponsor
- Nuon Therapeutics, Inc.
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial of tranilast in rheumatoid arthritis (RA) (3 arms), sponsored by Nuon Therapeutics, Inc. Primary endpoint: American College of Rheumatology 20% Response at 12 weeks. Started Mar 2009; status: completed.
02
Drugs
tranilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00882024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882024.